← Back to dossier
Patient handout

Migraine

PRODUCTION

1. Your condition

This handout is for migraine. Your care team identified this based on: recurrent unilateral throbbing headache 4–72h (aan 2024).

Other reasons your team may use this plan: visual / sensory / language aura preceding headache (aan 2024); photophobia, phonophobia, nausea/vomiting (aan 2024); ≥4 headache days/month interfering with function (aan 2024).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
ibuprofen400–800 mg PO at onsetPOPRN; max 3 d/week to avoid MOHAHS 2025 — high-dose NSAID first-line for mild-moderate; cap days/month to prevent MOH
naproxen500–550 mg PO at onsetPOPRNLonger half-life; useful for menstrual migraine (AAN 2024)
acetaminophen1000 mg PO at onsetPOPRNPregnancy-safe option (AAN 2024)

Plan: Acute attack treatment ladder (AAN 2024)

3. Your action plan

Use these zones to know what to do based on how you feel.

GREENNo headache or stable baseline (AAN 2024)
If you have:
  • No or mild headache
  • Function normal
  • Acute meds <2 days/week
Do this:
  • Take preventive as prescribed every day
  • Maintain trigger control: regular sleep, hydration, meals, exercise
  • Track in headache diary
  • Keep follow-up appointments
YELLOWActive migraine attack (AAN 2024)
If you have:
  • Attack onset (early aura or pain) (AAN 2024)
  • Pain ≥4/10 with photophobia / nausea
  • Function impaired
Do this:
  • Take rescue medication (NSAID, triptan, or gepant) at first sign of attack — earlier is better
  • Move to quiet, dark, cool environment
  • Hydrate; small meal if nausea allows
  • May repeat triptan once at 2 h if needed; do NOT exceed daily max
  • Use ondansetron / metoclopramide for nausea if prescribed
Call your provider if:
  • Attack lasts >24 hours despite acute treatment
  • Using rescue meds >2 days/week consistently (MOH risk)
  • New aura features or aura without headache
REDMedical alert — possible secondary headache or status migrainosus (AAN 2024)
If you have:
  • Sudden thunderclap "worst-of-life" headache
  • New focal weakness, vision loss, speech change, or confusion
  • Headache with fever and neck stiffness
  • Headache after head injury
  • Headache during pregnancy with vision change or RUQ pain
  • Headache lasting >72 hours despite treatment (status migrainosus)
Do this:
  • Call 911 / go to ED now
  • Do NOT take additional triptans / ergots — risk if non-migraine cause
  • Bring medication list
Call your provider if:
  • Any red-zone trigger — go directly to ED

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • Any SNOOP10 red flag (thunderclap, focal deficit, papilloedema, age >50, pregnancy/postpartum, immunocompromised, anticoagulated, post-trauma) (AAN 2024)
  • Aura with focal deficit lasting >60 min OR new aura pattern (AAN 2024)
  • Pregnancy + new aura + BP >140/90 OR RUQ pain (AAN 2024)
  • Hemiplegic migraine — fully reversible motor aura (ICHD-3 1.2.3); familial (FHM with CACNA1A/ATP1A2/SCN1A) or sporadic (SHM)
  • Migraine with brainstem aura (formerly basilar-type) — ≥2 of: dysarthria, vertigo, tinnitus, hyperacusis, diplopia, ataxia, decreased consciousness (ICHD-3 1.2.2)

5. Follow-up

Reassess at 3 mo; switch CGRP class if no ≥50% response; lifestyle (sleep/hydration/exercise/CBT for headache); comorbidity treatment (depression/anxiety/obesity) (AAN 2024)

6. Sources

Guideline: ICHD-3 (Olesen Cephalalgia 2018) + AHS 2024 Acute Treatment Consensus + AHS 2021 Preventive Consensus + AHS 2024 Position Statement (CGRP first-line preventive) + PREEMPT (onabotulinumtoxinA in chronic migraine) + ACP 2025 Prevention Guideline + AHS 2025 ED Acute Treatment

  1. pubmed.ncbi.nlm.nih.gov/29368949
  2. pubmed.ncbi.nlm.nih.gov/34160823
  3. pubmed.ncbi.nlm.nih.gov/38466028